Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Osteosarcoma × peginterferon alfa-2b × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 13 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Carcinoma, Renal Cell 5 Leukemia, Myeloid, Chronic-Phase 3 Kidney Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Neoplasm Metastasis 2 Lymphoma 2 Leukemia 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Thrombocytosis 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sezary Syndrome 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Mycosis Fungoides 1 Meningeal Carcinomatosis 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1

Interventions

Ifosfamide 27 Methotrexate 23 Doxorubicin 21 Cyclophosphamide 20 Cisplatin 19 Filgrastim 15 Etoposide 15 Gemcitabine 14 Leucovorin 12 Magnetic Resonance Spectroscopy 10 Temozolomide 9 Specimen Handling 9 Granulocyte Colony-Stimulating Factor 8 fludarabine 7 Zoledronic Acid 7 X-Rays 7 Sirolimus 7 Nivolumab 7 Neoadjuvant Therapy 7 Irinotecan 7 Docetaxel 7 Carboplatin 7 Biopsy 7 apatinib 6 Phantoms, Imaging 6 Mesna 6 cabozantinib 5 Vincristine 5 Topotecan 5 Radiotherapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00134030 2023-06-07

EURAMOS-1

Children's Oncology Group

Phase 3 Completed

1,334 enrolled 17 charts

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡